Company profile: Transferra Nanosciences
1.1 - Company Overview
Company description
- Provider of Chemistry Manufacturing and Controls services to biotechnology and pharmaceutical companies, specializing in the development and manufacture of complex drug delivery systems using lipid nanoparticle science.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Transferra Nanosciences
Molecular Imprints
HQ: United States
Website
- Description: Provider of nanopatterning systems and solutions for the hard disk drive and semiconductor sectors, with over 100 issued patents covering imprint tools, materials and masks/templates, process technology and imprint-specific device designs; founded in 2001 in Austin, Texas as a University of Texas spin-out.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Imprints company profile →
Illumina
HQ: United States
Website
- Description: Provider of next-generation sequencing platforms (NovaSeq, NextSeq, MiSeq) for genomic research and clinical applications; microarray kits and scanners for genotyping and epigenetics; library preparation kits for DNA and RNA; and DRAGEN bioinformatics for rapid genomic data analysis and management to analyze genetic variation and function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Illumina company profile →
InnoMedica
HQ: Switzerland
Website
- Description: Provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnoMedica company profile →
SCI Engineered Materials
HQ: United States
Website
- Description: Provider of specialized PVD thin film application products, offering sputtering targets, evaporation materials, advanced ceramic powders, substrates, and data sheets; a major retailer and manufacturer of specialized PVD thin film application products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SCI Engineered Materials company profile →
Aledia
HQ: France
Website
- Description: Provider of 3D LED and microLED display technologies, including silicon nanowire microLEDs for energy-efficient, high-resolution screens; WireLED using gallium nitride nanorods on silicon to cut cost and growth time; Nova Blue microLED for cost-effective mass production in small/mid-size displays; 3D microLEDs for smart devices and large displays; and SmartPixel for flexible, deformable, transparent HDR screens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aledia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Transferra Nanosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Transferra Nanosciences
2.2 - Growth funds investing in similar companies to Transferra Nanosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Transferra Nanosciences
4.2 - Public trading comparable groups for Transferra Nanosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →